The Redox State of Cytochrome C Modulates Resistance to Methotrexate in Human MCF7 Breast Cancer Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 May 16

PMID 23675469

Citations 5

Authors

Susana Barros

Nuria Mencia

Laura Rodriguez

Carlota Oleaga

Conceicao Santos

Veronique Noe

Carlos J Ciudad

Affiliations

Soon will be listed here.

Abstract

Background: Methotrexate is a chemotherapeutic agent used to treat a variety of cancers. However, the occurrence of resistance limits its effectiveness. Cytochrome c in its reduced state is less capable of triggering the apoptotic cascade. Thus, we set up to study the relationship among redox state of cytochrome c, apoptosis and the development of resistance to methotrexate in MCF7 human breast cancer cells.

Results: Cell incubation with cytochrome c-reducing agents, such as tetramethylphenylenediamine, ascorbate or reduced glutathione, decreased the mortality and apoptosis triggered by methotrexate. Conversely, depletion of glutathione increased the apoptotic action of methotrexate, showing an involvement of cytochrome c redox state in methotrexate-induced apoptosis. Methotrexate-resistant MCF7 cells showed increased levels of endogenous reduced glutathione and a higher capability to reduce exogenous cytochrome c. Using functional genomics we detected the overexpression of GSTM1 and GSTM4 in methotrexate-resistant MCF7 breast cancer cells, and determined that methotrexate was susceptible of glutathionylation by GSTs. The inhibition of these GSTM isoforms caused an increase in methotrexate cytotoxicity in sensitive and resistant cells.

Conclusions: We conclude that overexpression of specific GSTMs, GSTM1 and GSTM4, together with increased endogenous reduced glutathione levels help to maintain a more reduced state of cytochrome c which, in turn, would decrease apoptosis, thus contributing to methotrexate resistance in human MCF7 breast cancer cells.

Citing Articles

6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio) Hexanol Inhibits Proliferation and Induces Apoptosis of Endometriosis by Regulating Glutathione S-Transferase Mu Class 4.

Liu W, Cheng L, Du Y, Liu X, Ma J, Yan L Reprod Sci. 2023; 30(10):2945-2961.

PMID: 36928896 DOI: 10.1007/s43032-023-01207-x.

Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines.

Canevarolo R, Pereira de Souza Melo C, Cury N, Artico L, Correa J, Tonhasca Lau Y Front Oncol. 2022; 12:1032336.

PMID: 36531023 PMC: 9751399. DOI: 10.3389/fonc.2022.1032336.

Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.

Yang Y, Wu L, Shu X, Cai Q, Shu X, Li B J Natl Cancer Inst. 2019; 112(3):295-304.

PMID: 31143935 PMC: 7073907. DOI: 10.1093/jnci/djz109.

Altered protein S-glutathionylation identifies a potential mechanism of resistance to acetaminophen-induced hepatotoxicity.

McGarry D, Chakravarty P, Wolf C, Henderson C J Pharmacol Exp Ther. 2015; 355(2):137-44.

PMID: 26311813 PMC: 4631951. DOI: 10.1124/jpet.115.227389.

Effect of on MCF-7 breast cancer cell response to chemotherapeutic drugs.

Hertz E, Cadona F, Machado A, Azzolin V, Holmrich S, Assmann C Mol Clin Oncol. 2014; 3(1):37-43.

PMID: 25469267 PMC: 4251197. DOI: 10.3892/mco.2014.438.

References

Jolivet J, Cowan K, Curt G, Clendeninn N, Chabner B . The pharmacology and clinical use of methotrexate. N Engl J Med. 1983; 309(18):1094-104. DOI: 10.1056/NEJM198311033091805. View

Chu E, Grem J, Johnston P, Allegra C . New concepts for the development and use of antifolates. Stem Cells. 1996; 14(1):41-6. DOI: 10.1002/stem.140041. View

Townsend D, Tew K . The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003; 22(47):7369-75. PMC: 6361125. DOI: 10.1038/sj.onc.1206940. View

Blakley R, Cocco L . Dismutation of dihydrofolate by dihydrofolate reductase. Biochemistry. 1984; 23(11):2377-83. DOI: 10.1021/bi00306a009. View

Adler V, Yin Z, Fuchs S, Benezra M, Rosario L, Tew K . Regulation of JNK signaling by GSTp. EMBO J. 1999; 18(5):1321-34. PMC: 1171222. DOI: 10.1093/emboj/18.5.1321. View

Circu M, Aw T . Glutathione and apoptosis. Free Radic Res. 2008; 42(8):689-706. PMC: 3171829. DOI: 10.1080/10715760802317663. View

Ripple M, Abajian M, Springett R . Cytochrome c is rapidly reduced in the cytosol after mitochondrial outer membrane permeabilization. Apoptosis. 2010; 15(5):563-73. PMC: 2863113. DOI: 10.1007/s10495-010-0455-2. View

EVERSE J, Kujundzic N . Kinetics and mechanism of the reduction of horse heart ferricytochrome c by glutathione. Biochemistry. 1979; 18(12):2668-73. DOI: 10.1021/bi00579a037. View

Li M, Wang A, Xu J . Redox state of cytochrome c regulates cellular ROS and caspase cascade in permeablized cell model. Protein Pept Lett. 2008; 15(2):200-5. DOI: 10.2174/092986608783489490. View

10.

Tang S, Wu M, Wong R, Liu Y, Tang L, Lai C . Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer. Cancer. 2011; 117(14):3209-21. DOI: 10.1002/cncr.25875. View

11.

Liani E, Rothem L, Bunni M, Smith C, Jansen G, Assaraf Y . Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Int J Cancer. 2002; 103(5):587-99. DOI: 10.1002/ijc.10829. View

12.

Hancock J, Desikan R, Neill S . Cytochrome c, glutathione, and the possible role of redox potentials in apoptosis. Ann N Y Acad Sci. 2004; 1010:446-8. DOI: 10.1196/annals.1299.081. View

13.

McLellan L, Wolf C . Glutathione and glutathione-dependent enzymes in cancer drug resistance. Drug Resist Updat. 2001; 2(3):153-164. DOI: 10.1054/drup.1999.0083. View

14.

Deng H . Characterization of the reaction products of cytochrome c with glutathione by mass spectrometry. Biochem Biophys Res Commun. 2006; 342(1):73-80. DOI: 10.1016/j.bbrc.2006.01.108. View

15.

Moyer A, Sun Z, Batzler A, Li L, Schaid D, Yang P . Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev. 2010; 19(3):811-21. PMC: 2837367. DOI: 10.1158/1055-9965.EPI-09-0871. View

16.

Bracht K, Boubakari , Grunert R, Bednarski P . Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data. Anticancer Drugs. 2005; 17(1):41-51. DOI: 10.1097/01.cad.0000190280.60005.05. View

17.

Cho S, Lee Y, Park H, Ryoo K, Kang K, Park J . Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem. 2001; 276(16):12749-55. DOI: 10.1074/jbc.M005561200. View

18.

Gorlick R, Goker E, Trippett T, Steinherz P, Elisseyeff Y, Mazumdar M . Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood. 1997; 89(3):1013-8. View

19.

Tew K . Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 1994; 54(16):4313-20. View

20.

Kagan V, Tyurin V, Jiang J, Tyurina Y, Ritov V, Amoscato A . Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol. 2006; 1(4):223-32. DOI: 10.1038/nchembio727. View